Authors
Loading...
Review demonstrates scalable fabrication and targeted delivery of liposome platforms in therapeutic applications, highlighting industrial feasibility and regulatory compliance.
Akbarzadeh et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: